Glycemic control and weight loss benefits of fixed-ratio combinations of basal insulins and GLP1 receptor agonists in type 2 diabetes: A systematic review and network meta-analysis.
- DOI
- 10.1007/s12020-026-04857-4
- Published
- 2026 Oct 31
- Container
- Endocrine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s12020-026-04857-4,
title = {Glycemic control and weight loss benefits of fixed-ratio combinations of basal insulins and GLP1 receptor agonists in type 2 diabetes: A systematic review and network meta-analysis.},
author = {Kamrul-Hasan ABM and Mondal S and Nagendra L and Khalil I and Dutta D and Pappachan JM},
year = {2026},
journal = {Endocrine},
doi = {10.1007/s12020-026-04857-4},
url = {https://doi.org/10.1007/s12020-026-04857-4}
}RIS
TY - JOUR TI - Glycemic control and weight loss benefits of fixed-ratio combinations of basal insulins and GLP1 receptor agonists in type 2 diabetes: A systematic review and network meta-analysis. AU - Kamrul-Hasan ABM AU - Mondal S AU - Nagendra L AU - Khalil I AU - Dutta D AU - Pappachan JM PY - 2026 JO - Endocrine DO - 10.1007/s12020-026-04857-4 UR - https://doi.org/10.1007/s12020-026-04857-4 ER -
APA
ABM, K., S, M., L, N., I, K., D, D., & JM, P. (2026). Glycemic control and weight loss benefits of fixed-ratio combinations of basal insulins and GLP1 receptor agonists in type 2 diabetes: A systematic review and network meta-analysis.. Endocrine. https://doi.org/10.1007/s12020-026-04857-4
Source records
- pubmed · retrieved 2026-11-10T18:58:55.852Z
- europe-pmc · retrieved 2026-11-10T18:58:55.840Z